Effect of oral contraceptives on platelet monoamine oxidase, monoamine excretion, and adrenocortical function.
Studies with animals indicate that there are cyclical changes in the monoamine oxidase (MAO) activity of brain and uterus, and that these changes may be due to changes in estrogen and progesterone levels. To determine if oral contraceptives (OC) alter the tissue MAO activity of healthy women, we measured platelet MAO activity in 7 control women and in 7 women who were receiving combination estrogen-progesterone OC. The platelet MAO of the control women and the women receiving OC did not differ with the use of tryptamine and serotonin as MAO substrates. The two groups did not differ with respect to the following: serum serotonin, plasma tryptophan, plasma tyrosine, and the urinary excretion of tryptamine, tyramine, serotonin, 5-hydroxyindoleacetic acid, creatinine, 17-hydroxycorticosteroids, 17-ketosteroids, and urinary free cortisol. The subjects receiving OC had higher plasma cortisol concentrations than the controls. Two women in the seventh month of uncomplicated pregnancy, who underwent these studies, had higher plasma cortisol and urinary 17-ketosteroid excretion than control subjects. In the remaining tests the results of pregnant subjects did not differ from those of control subjects. We conclude that tissue MAO activity is not altered by OC or pregnancy.
D000302:Adrenal Cortex / Q000187:drug effects* / Q000502:physiology; D000305:Adrenal Cortex Hormones / Q000652:urine; D000311:Adrenal Glands / Q000187:drug effects*; D000328:Adult; D001679:Biogenic Amines / Q000097:blood / Q000652:urine*; D001792:Blood Platelets / Q000201:enzymology*; D003276:Contraceptives, Oral / Q000494:pharmacology*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008995:Monoamine Oxidase / Q000097:blood*; D011247:Pregnancy
D000305:Adrenal Cortex Hormones; D001679:Biogenic Amines; D003276:Contraceptives, Oral; D008995:Monoamine Oxidase; D006854:Hydrocortisone